Clinical Study
Risk Factor Analysis and Microbial Etiology of Surgical Site Infections following Lower Segment Caesarean Section
Table 2
(a) Resistance pattern in Gram-positive organisms (in %). (b) Resistance pattern in Gram-negative organisms (in %).
(a) |
| Org. | V | P | M | E | At | C | T | G | Co | Cp | Cu | Ac | Am |
| S. aureus | 0 | 66.7 | 23.8 | 15.8 | 14.28 | 66.67 | 28.6 | 25 | 44.4 | 56.25 | 64.3 | 35.7 | 46.7 | Enterococcus spp. | 0 | 50 | — | 100 | 0 | 0 | 0 | 66.7 | 50 | 100 | 0 | 0% | 0 | CONS | 0 | 16.6 | — | 0 | 16.67 | 0 | 0 | 0 | 0 | 60 | 100 | 60 | 66.67 |
|
|
V: vancomycin, P: penicillin, E: erythromycin, At: azithromycin, C: chloramphenicol, T: tetracycline, G: gentamicin, Co: cotrimoxazole, Cp: cephalexin, Ac: amoxicillin-clavulanic acid, and Am: amoxicillin.
|
(b) |
| Org. | Ak | Cf | Ci | Ce | Co | As | A | I | Ac | Nt | Sc | Pb | Ca | Ao |
| E. coli | 14.28 | 12.5 | 20.8 | 14.28 | 61.9 | 50 | 64.7 | 0 | 38.5 | 33.3 | 0 | 0 | 0 | 60 | Kleb. spp. | 16.67 | 16.67 | 33.3 | 0 | 72.2 | 5.5 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | C. freundii | 25 | 0 | 75 | 0 | 50 | 0 | 66.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | P. vulgaris | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | Ps. aeruginosa | 0 | 14.28 | 14.28 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Acineto. spp. | 36.58 | 31.7 | 68.29 | 81.8 | 67.6 | 9.3 | 91.67 | 0 | 0 | 0 | 9 | 20 | 18.7 | 50 |
|
|
Ak: amikacin, Cf: ciprofloxacin, Ci: ceftriaxone, Co: cotrimoxazole, As: ampicillin-sulbactam, A: ampicillin, I: imipenem, Ac: amoxicillin-clavulanic acid, Nt: netilmicin, Sc: sparfloxacin, Pb: polymyxin b, Ca: ceftazidime, and Ao: aztreonam.
|